Authors present distant results of treatment in 15 patients with laryngeal papillomatosis between 11 and 21 years of age treated from 1975 to 1994 in Warsaw ENT Clinic for Children by microsurgery m. Kleinsasser. The course of disease, methods of treatment, ending treatment age present voice function plus other conditions of larynx was analysed. The current therapy and advantages of microsurgical treatment used in our Clinic in patient with laryngeal papillomatosis (papillomatosis juvenile) has been showed. In the estimate group at 11 patients good function of fonation was as follow up confirmed. It was confirmed that this treatment is successful. The long term fonations results after microsurgery m. Kleinsasser appear in our opinion better then after laser therapy. It appear in future the best therapy should be a pharmacological treatment.
Download full-text PDF |
Source |
---|
Respir Res
December 2024
MSD, Puteaux, France.
Introduction: Recurrent respiratory papillomatosis (RRP) is a chronic disease caused by human papillomavirus (HPV), characterized by recurrent papillomas in the respiratory tract. Presenting as either juvenile-onset RRP (JoRRP) or adult-onset RRP (AoRRP), the severity of the disease is subjective and unpredictable. Lack of curative therapies necessitates disease management involving repeated surgical removal of lesions.
View Article and Find Full Text PDFMali Med
November 2024
Service ORL-CCF de l'Hôpital Général de Référence de Niamey.
Objective: to present the epidemiological, diagnostic, therapeutic and progressive aspects of laryngeal papillomatosis.
Patients And Method: This was a retrospective study over a period of 6 years (January 2016 to December 2021), covering cases of laryngeal papillomatosis collected at the Oto-Rhino-Laryngology department of the Niamey National Hospital.
Results: A total of 36 cases of laryngeal papillomatosis were recorded.
HNO
December 2024
Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie, Universitätsklinikum Würzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Deutschland.
At the 2024 international cancer congress of the American Society of Clinical Oncology (ASCO), studies on immuno-oncological therapeutic approaches for head and neck cancers once again took center stage. Following the trend of recent years, neoadjuvant immunotherapy has now reached a central role, and purely surgical studies have become increasingly scarce. This review article summarizes abstracts presented at the 2024 ASCO Annual Meeting that focus on surgical therapy or in which surgery was a significant component of the study protocol.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!